DarioHealth logo

DarioHealthNASDAQ: DRIO

Profile

Sector:

Healthcare

Country:

United States

IPO:

14 March 2016

Next earnings report:

28 March 2025

Last dividends:

N/A

Next dividends:

N/A
$27.82 M
-89%vs. 3y high
28%vs. sector
-vs. 3y high
-vs. sector
-81%vs. 3y high
26%vs. sector
-92%vs. 3y high
27%vs. sector

Price

after hours | Wed, 20 Nov 2024 22:57:54 GMT
$0.82+$0.01(+1.71%)

Dividend

No data over the past 3 years
$7.42 M$7.42 M
$7.42 M-$12.33 M

Analysts recommendations

Institutional Ownership

DRIO Latest News

DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
seekingalpha.com09 November 2024 Sentiment: NEUTRAL

DarioHealth Corp. (NASDAQ:DRIO ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Third Quarter 2024 Results Call. [Operator Instructions] This call is being recorded on November 7, 2024.

DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
zacks.com07 November 2024 Sentiment: POSITIVE

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.49 per share a year ago.

Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
prnewswire.com30 October 2024 Sentiment: POSITIVE

The new contract marks the eighth health plan for Dario and will contribute to revenues starting immediately. NEW YORK , Oct. 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract with a regional health plan in the Medicaid space, which has launched with the full suite of cardiometabolic solutions.

DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th
prnewswire.com23 October 2024 Sentiment: POSITIVE

Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 23, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a global leader in digital health, announced today that it will release its financial results for the 3rd quarter ended September 30th, 2024 and will host a conference call and webcast at 8:30 am Eastern Time, on Thursday, November 7th, 2024, before the market opens.     Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.

Twill by Dario to Offer a Benefit for AARP Members
prnewswire.com15 October 2024 Sentiment: POSITIVE

New offer gives Dario access to millions of AARP members, enabling engagement with people over 50 in health and well-being beginning in January 2025 NEW YORK , Oct. 15, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new AARP member benefit that provides members with proven digital behavioral health and well-being solutions from Twill by Dario. The new benefit is expected to launch in January of 2025 for AARP members.

All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy
zacks.com02 October 2024 Sentiment: POSITIVE

DarioHealth (DRIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Bet on 5 Top-Ranked Stocks With Rising P/E
zacks.com02 October 2024 Sentiment: POSITIVE

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Adverum Biotechnologies (ADVM), IceCure Medical (ICCM), DarioHealth (DRIO), Energous (WATT) and Virgin Galactic (SPCE).

DarioHealth And 2 Other Stocks Under $5 Executives Are Buying
benzinga.com13 September 2024 Sentiment: POSITIVE

The Dow Jones index closed higher by more than 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes
prnewswire.com12 September 2024 Sentiment: POSITIVE

The integration of Twill's condition-specific, expert-led peer groups will enhance the member experience and deepen engagement with Dario's proven cardiometabolic solution NEW YORK , Sept. 12, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market announced today the integration of condition-specific communities and peer groups with personalized navigation capabilities into its cardiometabolic solution to improve outcomes-based engagement, marking a significant milestone in the integration of the Dario-Twill product offering.

Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
prnewswire.com10 September 2024 Sentiment: POSITIVE

New Research Confirms the Benefit of Dario's Integrated, Data-Driven Approach to Health and Chronic Condition Management NEW YORK , Sept. 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market announced today the publication of a new study in the peer-reviewed journal Frontiers in Endocrinology.

What type of business is DarioHealth?

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

What sector is DarioHealth in?

DarioHealth is in the Healthcare sector

What industry is DarioHealth in?

DarioHealth is in the Health Information Services industry

What country is DarioHealth from?

DarioHealth is headquartered in United States

When did DarioHealth go public?

DarioHealth initial public offering (IPO) was on 14 March 2016

What is DarioHealth website?

https://www.dariohealth.com

Is DarioHealth in the S&P 500?

No, DarioHealth is not included in the S&P 500 index

Is DarioHealth in the NASDAQ 100?

No, DarioHealth is not included in the NASDAQ 100 index

Is DarioHealth in the Dow Jones?

No, DarioHealth is not included in the Dow Jones index

When was DarioHealth the previous earnings report?

No data

When does DarioHealth earnings report?

The next expected earnings date for DarioHealth is 28 March 2025